A Phase 3, Multi-Center, Open-Label, Randomized, Clinical Trial Evaluating the Efficacy and Safety of Technosphere Insulin Inhalation Powder in Combination With Lantus Versus Humalog in Combination With Lantus in Subjects With Type 1 Diabetes Mellitus Over a 16-Week Treatment Period
Phase of Trial: Phase III
Latest Information Update: 21 Oct 2014
At a glance
- Drugs Insulin (Primary) ; Insulin glargine; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors MannKind Corporation
- 15 Oct 2014 Status changed from completed to discontinued, as reported by the ClinicalTrials.gov record.
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
- 28 Jun 2011 Treatment satisfaction outcomes presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History